# Regulation of cardiomyocyte proliferation by the Reptin ATPase

> **NIH NIH F31** · HARVARD MEDICAL SCHOOL · 2024 · $3,000

## Abstract

ABSTRACT: Cardiomyocyte proliferation is an important source of new myocardium during heart development
and regeneration. After birth cardiomyocytes are highly resistant to proliferation. The lack of adult cardiomyocyte
proliferation precludes cardiac repair and underlies the high morbidity and mortality rates associated with
congenital heart defects and adult cardiovascular disease. Therefore, identifying novel regulators of
cardiomyocyte proliferation is key to the development of regenerative heart therapies. Zebrafish are a well-
established model to study cardiac development and regeneration because their cardiomyocytes maintain a
remarkable capacity to proliferate allowing the heart to regenerate after adult injury. Our lab recently reported
that the AAA+ ATPase Reptin is a potent suppressor of cardiomyocyte proliferation. Reptin is a known
component of the Tip60 and INO80 complexes which have roles in DNA damage repair and chromatin
remodeling. Our lab demonstrated in zebrafish that reptin loss of function mutations cause myocardial
hyperplasia at 3 days post fertilization (dpf). We showed that cardiomyocyte-specific overexpression of reptin
rescues the cardiomyocyte hyperproliferation phenotype. We further demonstrated that inducible overexpression
of reptin after adult cardiac injury resulted in decreased cardiomyocyte proliferation and failure to regenerate.
Expanding on our published data, I propose to study the molecular mechanisms by which Reptin suppresses
cardiomyocyte proliferation. Preliminary data suggests that the ATPase function of Reptin is essential to dampen
proliferation at 3 dpf. RNA sequencing of reptin mutant and control cardiomyocytes at 3 dpf revealed the
unanticipated result that the hyperproliferative reptin mutant cardiomyocytes upregulate both pro-proliferative
(e.g. fosl1a & junba) and anti-proliferative (e.g. tp53 & cbx7a) transcripts. Analysis at 4 and 5 dpf revealed that
the reptin mutant cardiomyocytes lose their hyperproliferative phenotype by 4 dpf and have significantly reduced
proliferation rates compared to controls at 5 dpf. I hypothesize: 1) that reptin mutant cardiomyocytes require
AP-1 activity for their initial proliferative burst where DNA damage accumulates and triggers tp53
upregulation to halt cell division, and 2) that compensatory upregulation of the PRC1 complex
component cbx7a drives an anti-proliferative chromatin landscape in reptin mutant cardiomyocytes. In
Aim 1, I will assess the sufficiency of AP-1 family members to drive cardiomyocyte proliferation in embryonic
zebrafish, the accumulation of DNA damage in hyperproliferative reptin mutant cardiomyocytes, and the role of
tp53 upregulation in DNA damage signaling and cell cycle arrest in reptin mutant hearts. In Aim 2, I will identify
changes in the chromatin landscape that are associated with reptin loss of function and correlate those
alterations to changes in gene expression. I will also investigate the ability of cbx7a to dampen cardi...

## Key facts

- **NIH application ID:** 11175835
- **Project number:** 3F31HL170493-01S1
- **Recipient organization:** HARVARD MEDICAL SCHOOL
- **Principal Investigator:** Felicia E Wranitz
- **Activity code:** F31 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $3,000
- **Award type:** 3
- **Project period:** 2023-09-30 → 2025-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11175835

## Citation

> US National Institutes of Health, RePORTER application 11175835, Regulation of cardiomyocyte proliferation by the Reptin ATPase (3F31HL170493-01S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11175835. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
